Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The 90-day beyond-use date gives sublingual formulations a significant practical advantage
Retatrutide is a novel triagonist peptide that simultaneously targets three critical metabolic receptors: Glucagon-like peptide-1 (GLP-1) Glucose-dependent insulinotropic polypeptide (GIP) Glucagon Originally developed for clinical research into obesity and metabolic disorders, retatrutide is designed to support extensive scientific exploration of: Weight reduction Improved glucose management Enhanced metabolic function What Key Benefits Does Retatrutide Offer
Unlike other drugs, KPV peptide therapy is a treatment that supports gut healing without suppressing the immune system
Additionally, semaglutide curtails the secretion of the hormone glucagon, which otherwise prompts the liver to produce more glucose
Improved Recovery : Some studies show it reduces muscle soreness after exercise
